Asked by: Baroness Bennett of Manor Castle (Green Party - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government what assessment they have made of the report Antibiotic underdosing and disposal in NHS organisations across Great Britain, published in November 2023; and what discussions they have had with the Care Quality Commission on integrating line flushing policies and practices into the assessment framework for care provided in England.
Answered by Lord Markham - Parliamentary Under-Secretary (Department of Health and Social Care)
Officials are aware of, and have considered, the findings of the report Antibiotic underdosing and disposal in NHS organisations across Great Britain. Officials from the Department have not had any recent discussions with the Care Quality Commission on integrating line flushing policies and practices into the assessment framework for care provided in England.
General guidance on prescribing and the use of medicines is published by the National Institute for Health and Care Excellence in an online-only format. Good clinical practice is to flush an intravenous line with saline after a medicine has been administered, to ensure the full dose is delivered to the patient. This is not unique to antibiotics.
Asked by: Christopher Chope (Conservative - Christchurch)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how much the administration of the Vaccine Damage Payment Scheme cost the NHS Business Services Authority in (a) 2021, (b) 2022 and (c) 2023.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
The NHS Business Services Authority (NHSBSA) administers the Vaccine Damage Payment Scheme, on behalf of the Department. Administration costs for the scheme were £600,000, £8.8 million, and £16.1 million for April 2021 to March 2022, April 2022 to March 2023, and April 2023 to March 2024, respectively. Payments made by the NHSBSA for the provision of medical records totalled £1,200, £72,000, and £73,100, for the same periods. The figures are provided to the nearest decimal place.
Asked by: Rosena Allin-Khan (Labour - Tooting)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how many adult mental health patients have been held in inappropriate out of area placements since March 2021.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
12,960 inappropriate out of area placements were started between April 2021 and 31 December 2023, although some patients may have had more than one placement within the reporting period.
Asked by: Helen Grant (Conservative - Maidstone and The Weald)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps her Department is taking to reduce ambulance response times.
Answered by Helen Whately - Minister of State (Department of Health and Social Care)
Our Delivery plan for recovering urgent and emergency care services sets out the range of measures being taken to achieve our ambition of reducing average Category 2 ambulance response times to 30 minutes, across 2024/25. Further information on the delivery plan is available at the following link:
Ambulance trusts received £200 million of additional funding in 2023/24 to increase deployed hours and reduce response times. We will maintain the improved ambulance service capacity from this additional funding in 2024/25, alongside the additional 5,000 permanent hospital beds delivered last year to improve patient flow through accident and emergency, and reduce ambulance capacity lost due to handover delays.
There have been significant improvements in performance across the country, with average Category 2 ambulance response times in 2023/24 over 13 minutes faster compared to the previous year, a reduction of over 27%.
Asked by: Andy Carter (Conservative - Warrington South)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps she is taking to help increase uptake of the shingles vaccine by people aged over 65 in Warrington.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
The Joint Committee on Vaccination and Immunisation has recommended that those who are eligible for the shingles vaccine should change, to allow individuals to be protected at an earlier age, particularly those that have a weakened immune system. Based on the evidence, they recognised that there may be more clinical benefit from starting shingles vaccinations at a lower age, with modelling indicating that a greater number of cases of shingles would be prevented with vaccination at 60 years old for immunocompetent individuals, and 50 years old for immunosuppressed individuals. The committee advised that the programme should be implemented in stages, starting with those that are over 50 years old with a weakened immune system and those turning 65 and 70 years old, then eventually moving down to those turning 60 years old. This is a similar pattern to the roll out of the shingles vaccine from 2013. This is why the vaccine offer has been expanded to all those turning 65 and 70 years old and all those over 50 years old with a weakened immune system, from 1 September 2023. The programme began on 1 September 2023 and will run until 31 August 2028, offering the vaccine to people as they turn 65 and 70 years old, until the offer has been made to all those aged 65 to 70 years old. It will then expand to offering the vaccine to all those that are turning 60 and 65 years old, from 1 September 2028.
The shingles vaccine is available through general practice (GP) surgeries in primary care, and GPs are required to identify and put in place a call or recall arrangement to offer the shingles vaccination to eligible patients. All eligible patients are contacted by their GP surgery to invite them for vaccination. The GP will then follow up with letters or with calls and text messages, to encourage eligible people that have not come forward to take up the offer.
There is a wide range of public facing information to help increase uptake of the shingles vaccine, and to publicise the programme in GP surgeries and online, including display bunting, leaflets, and posters. GPs are also adding messages regarding shingles to their practice websites, prescription counterfoils, and social media banners. Public facing information regarding the shingles vaccination programme includes translations into over 20 different languages including braille, audio, large print, and British Sign Language. Information for healthcare professionals, including GP toolkits for improving uptake of shingles vaccination, has also been produced and published by local immunisation commissioning teams.
Asked by: Royston Smith (Conservative - Southampton, Itchen)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 9 April 2024 to Question 20081 on Gender Dysphoria: Children, what information her Department holds on the number of children of each biological sex that were prescribed puberty blockers for treatment of gender dysphoria each year since 2010.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
The Department does not hold information on the number of children of each biological sex who were prescribed puberty blockers for treatment of gender dysphoria.
Asked by: John Hayes (Conservative - South Holland and The Deepings)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether (a) Ministers and (b) officials from her Department have met Stonewall to discuss puberty blockers in the last five years.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
Ministers have not met Stonewall to discuss puberty blockers. Information on how many times officials have met with Stonewall is not available, and could only be obtained at disproportionate cost.
Asked by: Karin Smyth (Labour - Bristol South)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what discussions she has had with Integrated Care Boards on recruitment and retention of health workers.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
The NHS Long Term Workforce Plan sets out how we will meet the workforce needs of the future, through increasing training numbers and reforming training, working differently, and taking action to retain more staff.
There are a number of key national programmes aimed at supporting regions, integrated care boards (ICBs), and providers with recruitment challenges, and growing the workforce. For example, the Overhauling Recruitment programme aims to overhaul and modernise National Health Service recruitment, encouraging innovation and wider access into NHS careers, supporting the growth of a diverse and skilled workforce to meet future demands on healthcare. NHS England will soon be engaging with ICBs and providers to support and enable this transformational change, as it prepares to publish the overhauling recruitment strategic delivery framework.
The NHS Long Term Workforce Plan also sets out how to improve culture and leadership to ensure that up to 130,000 fewer staff leave the NHS over the next 15 years. Key to this is the National Retention Programme. The programme builds on the NHS People Promise, and supports integrated care systems (ICS), which are made up of ICBs and integrated care partnerships, regions, NHS trusts, and organisations, to improve employee experience and retain their people, thereby reducing NHS staff leaver rates.
Support for organisations and ICS can be accessed via the Retention Hub, which outlines initiatives mapped against the People Promise, access to tools, guides, and case studies, to enable improvements and contact details for regional colleagues to support the retention agenda in each of the seven regions.
Asked by: Rachael Maskell (Labour (Co-op) - York Central)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether she is taking steps to ensure that family hubs provide advice on smoking and vaping harm reduction.
Answered by Andrea Leadsom - Parliamentary Under-Secretary (Department of Health and Social Care)
Smoking is the number one entirely preventable cause of ill-health, disability, and death in this country. It is responsible for 80,000 yearly deaths in the United Kingdom, and one in four of all UK cancer deaths. It costs our country £17 billion a year, £14 billion of which is through lost productivity alone. It puts a huge pressure on the National Health Service and social care, costing over £3 billion a year.
The Government is investing an additional £300 million to improve support for families, though the joint Department of Health and Social Care and Department for Education Family Hubs and Start for Life programme. The Family Hubs and Start for Life programme guide sets out minimum expectations that local authorities receiving programme funding should deliver by March 2025. With regards to smoking support, the programme guide sets out that staff in a family hub are expected to be trained in delivering Very Brief Advice on smoking to parents identified as smokers, and some family hubs may provide smoking cessation support on-site, for example through drop-ins.
Staff in family hubs know what stop smoking services (SSS) are provided locally, and connect families to these services. Smokers are three times as likely to succeed with SSS, when compared to an unsupported quit attempt. As announced in Stopping the start: our new plan to create a smokefree generation, published in October 2023, the Government is investing an additional £70 million per year, for five years, to support local authority led SSS, almost doubling current spend and supporting 360,000 people to set a quit date each year.
In addition, we are establishing a financial incentives scheme to help pregnant smokers and their partners to quit smoking, with smoking cessation support. This evidence-based intervention will encourage pregnant women to give up smoking, and remain smokefree throughout pregnancy and beyond, helping to improve the health and wellbeing of both mother and baby.
Whilst anyone smoking should focus on giving up cigarettes before giving up vaping, giving up vaping is an important step in overcoming nicotine dependence. We are working with the NHS Better Health website to provide advice for people who want to quit vaping. The National Centre for Smoking Cessation and Training has produced guidance for local SSS staff, on how best to support vapers to quit. We are also exploring further ways to support people to quit vaping, as part of the national Swap to Stop programme.
Asked by: Rachael Maskell (Labour (Co-op) - York Central)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what discussions she has had with community pharmacists on supporting people with (a) smoking and (b) vaping (i) addiction and (ii) dependency.
Answered by Andrea Leadsom - Parliamentary Under-Secretary (Department of Health and Social Care)
Quitting smoking is the best thing a smoker can do for their health and smokers are three times as likely to succeed with stop smoking services (SSS) when compared to an unsupported quit attempt. As announced in Stopping the start: our new plan to create a smokefree generation, published in October 2023, the Government is investing an additional £70 million per year for five years to support local authority-led SSS, around doubling current spend and supporting 360,000 people to set a quit date each year. Local authorities commission a variety of settings, including community pharmacy, to deliver SSS. In 2022/23, 12,165 of the 176,566 quit dates set through SSS were in a pharmacy setting. Since March 2022, hospitals have been referring patients to community pharmacy to continue the stop smoking journey they started in hospital as part of the NHS Smoking Cessation Service in community pharmacies agreed by the Department, NHS England and Community Pharmacy England. Across the country, 4841 community pharmacies have signed up to deliver the service.
In addition, we are establishing a financial incentives scheme to help pregnant smokers and their partners to quit smoking, with smoking cessation support. This evidence-based intervention will encourage pregnant women to give up smoking, and remain smokefree throughout pregnancy and beyond, helping to improve the health and wellbeing of both mother and baby.